Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier
Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier
复制标题
荧光标记维拉帕米在血视网膜屏障处的血液至视网膜转运
DOI:
10.1007/s11095-018-2384-7
复制
发表时间:
2018
影响因子:
3.7
通讯作者:
Hosoya Ken-ichi
中科院分区:
文献类型:
--
作者:
Kubo Yoshiyuki;Nakazawa Ayumi;Akanuma Shin-ichi;Hosoya Ken-ichi
PurposeTo investigate the blood-to-retina verapamil transport at the blood-retinal barrier (BRB).MethodsEverFluor FL Verapamil (EFV) was adopted as the fluorescent probe of verapamil, and its transport across the BRB was investigated with common carotid artery infusion in rats. EFV transport at the inner and outer BRB was investigated with TR-iBRB2 cells and RPE-J cells, respectively.ResultsThe signal of EFV was detected in the retinal tissue during the weak signal of cell impermeable compound. In TR-iBRB2 cells, the localization of EFV differed from that of LysoTracker®Red, a lysosomotropic agent, and was not altered by acute treatment with NH4Cl. In RPE-J cells, the punctate distribution of EFV was partially observed, and this was reduced by acute treatment with NH4Cl. EFV uptake by TR-iBRB2 cells was temperature-dependent and membrane potential- and pH-independent, and was significantly reduced by NH4Cl treatment during no significant effect obtained by different extracellular pH and V-ATPase inhibitor. The EFV uptake by TR-iBRB2 cells was inhibited by cationic drugs, and inhibited by verapamil in a concentration-dependent manner with an IC50of 98.0 μM.ConclusionsOur findings provide visual evidence to support the significance of carrier-mediated transport in the blood-to-retina verapamil transport at the BRB.